Atinary and Snapdragon showcases self-driving labs technology with cutting-edge lab and process development capabilities to revolutionize drug development.
Atinary announces a strategic collaboration with Snapdragon Chemistry, a Cambrex company, to revolutionize advanced drug development.
This collaboration integrates Snapdragon’s proprietary LabOS™ software with Atinary’s SDLabs™ platform, to create a fully automated, AI-driven medium-throughput Solid-Phase Oligonucleotide Synthesizer (SPOS) for the purpose of autonomous multi-objective process optimizations.
By using Atinary’s AI platform, Snapdragon’s process optimization campaign has demonstrated significant improvements across the tested applications, with up to an 18% increase in product yield and a 22% reduction in cost, surpassing expert-optimized results.
More information in the full press release.
Follow Atinary Technologies on LinkedIn & visit our website to learn more about our Self-Driving Labs technology and how AI can turbocharge your R&D processes today.